Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Prepaid Assets (2016 - 2025)

Fortress Biotech has reported Prepaid Assets over the past 13 years, most recently at $4.9 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $4.9 million for Q4 2025, down 31.15% from a year ago — trailing twelve months through Dec 2025 was $4.9 million (down 31.15% YoY), and the annual figure for FY2025 was $4.9 million, down 31.15%.
  • Prepaid Assets for Q4 2025 was $4.9 million at Fortress Biotech, up from $2.3 million in the prior quarter.
  • Over the last five years, Prepaid Assets for FBIO hit a ceiling of $12.1 million in Q1 2024 and a floor of $2.3 million in Q3 2025.
  • Median Prepaid Assets over the past 5 years was $5.7 million (2022), compared with a mean of $6.2 million.
  • Biggest five-year swings in Prepaid Assets: surged 144.54% in 2021 and later crashed 60.78% in 2025.
  • Fortress Biotech's Prepaid Assets stood at $7.1 million in 2021, then soared by 36.73% to $9.7 million in 2022, then grew by 8.68% to $10.5 million in 2023, then crashed by 32.29% to $7.1 million in 2024, then tumbled by 31.15% to $4.9 million in 2025.
  • The last three reported values for Prepaid Assets were $4.9 million (Q4 2025), $2.3 million (Q3 2025), and $7.0 million (Q2 2025) per Business Quant data.